Find a Clinical Trial | Rutgers Cancer Institute of New Jersey

Find a Clinical Trial

Print this page

A phase I single-agent open-label dose-escalation study of oral ONC201 in patients with advanced solid tumors
Protocol: 051403

Principal Investigator: Mark Stein

Applicable Disease Sites: Kidney
Prostate
Any Site
Breast - Male
Brain and Nervous System
Melanoma, skin
A Phase 2 Randomized Discontinuation Trial in Patients with Hormone-Dependent Rising Prostate-Specific Antigen Progression After Local Therapy For Prostate Cancer Evaluating the Synergy of Metformin Plus Aspirin (PRIMA Trial)
Protocol: 081501

Principal Investigator: Mark Stein

Applicable Disease Sites: Prostate
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer: The TRANSFORMER Trial
Protocol: 081508

Principal Investigator: Mark Stein

Applicable Disease Sites: Prostate
11-497: PARTIQoL: Prostate Advanced Radiation Technologies Investigating Quality of Life. A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer.
Protocol: 081510

Principal Investigator: Rahul Parikh

Applicable Disease Sites: Prostate
Randomized Three-Arm Trial to Evaluate the Effect of Neoadjuvant Apalutamide Alone or in Combination with Abiraterone acetate and GnRH Agonist on Enhancing Surgical Outcome of Nerve-Sparing Radical Prostatectomy in Men with High-Risk Prostate Cancer (Multi-Center)
Protocol: 081603

Principal Investigator: Isaac Kim

Applicable Disease Sites: Prostate
PCCTC #: c16-168: A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (PCCTC 16-168)
Protocol: 081701

Principal Investigator: Anna Ferrari

Applicable Disease Sites: Prostate

Proud member of

Rutgers Cancer Institute of New Jersey

195 Little Albany Street
New Brunswick, NJ 08903-2681
732-235-CINJ (2465)

Copyright ©2017 Rutgers, The State University of New Jersey, all rights reserved | Privacy Policy

Rutgers Cancer Institute of New Jersey is the state's only National Cancer Institute-designated Comprehensive Cancer Center

The information contained in this website is not a substitute for medical consultation. A physician should always be consulted for any health problem or medical condition.